Oct 16, 2019 · 18m · top-founders
1544 1 Day After $1.4B Exit He Launches LifeOmic to Tackle Precision Health Using AI and Machine Learning
0:00 / 0:00
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
Serial software entrepreneur and physician Dr. Don Brown discusses his multi-decade journey scaling Interactive Intelligence to a $1.4 billion exit and immediately launching LifeOmic to revolutionize precision healthcare through cloud computing, AI, and genomic data integration.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Nathan holds 38% of the talking time here. How this is scored →
Nathan as informed peer 4.6 Guest teaching 2.7 Guest disagreement 1.4 Nathan pushing back 2.9
speaking balance: gold is Nathan, purple is the guest (3 minute bins)
Sharpest disagreement ▶ 8:36 Don forcefully rejects VC funding premise
Don counters Nathan's premise that founders should risk OPM, emphatically stating that self-funding lets him do whatever he wants without answering to outside investors.
Hardest push from Nathan ▶ 5:56 Nathan demands exact billing metricWhen Don vaguely describes pricing by computational load, Nathan cuts in repeatedly asking what concrete metric is being measured.
Biggest teaching moment ▶ 1:36 Don breaks down precision medicineNathan openly acknowledges he doesn't know what precision medicine means, leading Don to clearly lay out the shift from trial-and-error medicine to targeted genomic therapy.
Nathan holds their own ▶ 14:52 Nathan details international M&A distribution playbookNathan references Don's specific acquisitions in Australia and Germany by name to illustrate a masterclass lesson on why founders should acquire distribution pipelines.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | Nathan as informed peer | Guest teaching | Guest disagreement | Nathan pushing back | Why |
|---|---|---|---|---|---|---|
| Defining Precision Medicine and LifeOmic's Core Platform | 1 | 5 | 1 | 1 | Nathan explicitly admits ignorance and asks Don to educate him on what precision medicine means. Don explains the current trial-and-error state of medicine and how genomic data customizes cancer treatments. | |
| Genomic Data, EMR Integration, and Machine Learning Inputs | 5 | 4 | 2 | 4 | Nathan probes into data acquisition, challenging whether users must opt in and if genomic data is the sole asset. Don clarifies how institutional clinical partnerships differ from direct consumer uploads. | |
| Monetization Strategy, Pricing Structure, and Enterprise Contracts | 6 | 2 | 1 | 5 | Nathan pushes Don on the exact pricing mechanics and metrics measuring computational load. Don explains that their pricing directly abstracts the underlying AWS compute and storage cost model. | |
| Self-Funding Advantages, Hiring Strategy, and Team Footprint | 3 | 2 | 2 | 3 | Nathan asks why Don is risking his own money rather than taking outside venture funding. Don articulates the freedom of self-funding, which allows him to hire top talent without premature revenue pressure. | |
| Scaling Interactive Intelligence: From Startup to Cloud Provider | 7 | 2 | 1 | 3 | Nathan demonstrates solid preparation regarding Interactive Intelligence's historical financial milestones and IPO valuation bubble. Don candidly recounts watching his stock surge and plunge from $54 to under $2. | |
| Strategic M&A and the Power of Owning Distribution Channels | 8 | 3 | 2 | 3 | Nathan names specific past acquisitions like AcroSoft, CallTime, and Agora to discuss roll-up strategy. Don clarifies they bought regional distribution networks rather than technology roll-ups, prompting Nathan to analyze the advantages of channel ownership. | |
| The Famous Five Rapid-Fire Lightning Round | 2 | 1 | 1 | 1 | Nathan runs through his standard rapid-fire questions, reacting with surprise to Don's personal details, including his 8 children. |
Statements from this episode (15)
Brown: LifeOmic Has Not Yet Determined Its Revenue Model
“I, well, we're still trying to figure out the revenue model. We're more concerned right now about building a cloud-based platform for precision medicine.”
Brown: LifeOmic and IU Medicine Are Modeling Cancer Patient Treatment Responses
“We're working with large academic medical centers like at all my alma mater, the Indiana University School of Medicine. They're loading up information about thousands of cancer patients to try to use our machine learning and other techniques to figure out who'…”
Brown: Most genes are shaped by environmental exposure, not pure determinism
“There are a few genes where if you've been dealt a bad hand, you know that's just the luck of the draw, but most genes really are affected by the environment, and so it's that combination of your whole genome sequence and your environmental exposure.”
Brown: LifeOmic prices software based on AWS compute and storage metrics
“We basically charge based upon the amount of data and the sort of computational load that it imposes.
[357] Podcast Host: Measured by what?
[359] Don Brown: I'm sorry?
[360] Podcast Host: What's the actual metric you're measuring?
[361] Podcast Host: Computati…”
Brown: Precision medicine will filter down into corporate wellness programs
“We really think this whole notion of precision medicine, precision health will filter down into corporate wellness programs.”
Brown: LifeOmic plans freemium model for corporate wellness platform
“We plan to offer kind of a freemium model where organizations can use our mobile app and our cloud platform for free for their
[483] Don Brown: employees or members.
[486] Don Brown: and then we have more specialized services that we can offer on top of what …”
Brown: LifeOmic is completely self-funded out of pocket
“No, I've funded it all out of pocket myself so far.”
Brown: Self-funding frees founders from answering to investors and short-term revenue
“I, you know, when it's your own capital at risk, you can do whatever the hell you want, and you don't have to answer to anybody. You don't have to be overly concerned about generating revenue.”
Brown: Interactive Intelligence grew revenue from $1.5M to $18M at 1999 IPO
“We, ah, we released our product in 97 and, ah, did 1.5 million dollars in revenue. In 98, we did nine million dollars. In 99, when we went public, we did eighteen million dollars in revenue.”
Brown: Interactive Intelligence hit a $750M market cap within one year of IPO
“We popped, within a year, we had a three-quarter of a billion dollar market cap.”
Brown Refused to Sell Interactive Intelligence Stock During Dot-Com Peak
“You know, I didn't sell any stock. I, for one thing, it just felt unreal. And it just felt wrong on some level that I just didn't feel right about selling stock at that sort of valuation.”
Brown: Interactive Intelligence stock crashed from ~$54 to under $2
“The stock price went from a high of, I think, 54 bucks a share back then to a low of under two dollars. Within three or four years”
Don Brown: Interactive Intelligence prioritized acquiring distributors over tech tuck-ins
“We didn't exactly do a roll-up. We did a few tuck-in acquisitions along the way. I'm an engineer by you know, by training, and so I always think I can build something better than anybody else, and that makes it kind of hard to do acquisitions, at least for tec…”